HOOKIPA Pharma (HOOK) IPO Opens 2% Higher

Today's IPO for HOOKIPA Pharma Inc. (NASDAQ: HOOK) opened for trading a $14.30 after pricing 6,000,000 shares of common stock at a public offering price of $14.00 per share.

In addition, HOOKIPA has granted the underwriters a 30-day option to purchase up to 900,000 additional shares of common stock at the initial public offering price, less underwriting discounts and commissions.

BofA Merrill Lynch, SVB Leerink, and RBC Capital Markets are serving as joint book-running managers for the offering. Kempen is acting as a co-manager for the offering.

HOOKIPA Pharma Inc. is a clinical stage biopharmaceutical company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body’s immune system.

You May Also Be Interested In

• Doncasters (DPC) indicating open around $40, IPO priced at $33
• ChainOn Group files for IPO on Nasdaq at $4-$6 per share
• Sinda opens at $10.80, IPO priced at $12